Suzhou Basecare Medical Corporation Limited
HKEX:2170.HK
3.25 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 207.976 | 140.901 | 107.299 | 81.109 | 55.685 | 32.609 |
| Cost of Revenue
| 116.625 | 81.373 | 56.152 | 53.395 | 29.432 | 24.472 |
| Gross Profit
| 91.351 | 59.528 | 51.147 | 27.714 | 26.253 | 8.137 |
| Gross Profit Ratio
| 0.439 | 0.422 | 0.477 | 0.342 | 0.471 | 0.25 |
| Reseach & Development Expenses
| 129.566 | 119.773 | 73.711 | 34.481 | 19.885 | 18.817 |
| General & Administrative Expenses
| 105.425 | 81.396 | 52.112 | 25.244 | 2.549 | 2.882 |
| Selling & Marketing Expenses
| 103.876 | 80.099 | 62.524 | 16.616 | 11.011 | 10.866 |
| SG&A
| 209.301 | 161.495 | 114.636 | 41.86 | 13.56 | 13.748 |
| Other Expenses
| -53.807 | 2.238 | 2.436 | 0.668 | 0.591 | 0.878 |
| Operating Expenses
| 334.744 | 277.804 | 196.272 | 82.473 | 36.513 | 61.046 |
| Operating Income
| -193.709 | -126.118 | -124.486 | -53.468 | -8.73 | -51.816 |
| Operating Income Ratio
| -0.931 | -0.895 | -1.16 | -0.659 | -0.157 | -1.589 |
| Total Other Income Expenses Net
| -2.61 | -0.496 | -1.26 | -828.05 | -521.84 | -105.189 |
| Income Before Tax
| -196.319 | -126.614 | -125.746 | -881.518 | -530.57 | -157.005 |
| Income Before Tax Ratio
| -0.944 | -0.899 | -1.172 | -10.868 | -9.528 | -4.815 |
| Income Tax Expense
| -2.97 | 6.013 | 18.332 | -7.394 | -2.29 | -5.069 |
| Net Income
| -191.685 | -123.163 | -143.651 | -877.052 | -531.336 | -154.877 |
| Net Income Ratio
| -0.922 | -0.874 | -1.339 | -10.813 | -9.542 | -4.75 |
| EPS
| -0.7 | -0.45 | -0.54 | -3.29 | -1.99 | -0.58 |
| EPS Diluted
| -0.7 | -0.45 | -0.54 | -3.29 | -1.99 | -0.58 |
| EBITDA
| -174.142 | -117.731 | -118.882 | -873.324 | -520.882 | -148.017 |
| EBITDA Ratio
| -0.837 | -0.841 | -1.108 | -0.575 | -0.024 | -1.352 |